Biotech · Private company
Idorsia Pharmaceuticals Ltd.
Track this companyFree. Adds Idorsia Pharmaceuticals Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials255 recruiting or active
Pipeline programs29From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline29
- Aprocitentan 12.5 mgPhase 3 · Resistant HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Aprocitentan 25 mgPhase 3 · Resistant HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- ClazosentanPhase 3 · Aneurysmal Subarachnoid HemorrhageClinicalTrials.gov · fetched Nov 12, 2026
- DaridorexantPhase 3 · Insomnia DisorderClinicalTrials.gov · fetched Nov 12, 2026
- DaridorexantPhase 3 · Insomia DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Daridorexant 25 mgPhase 3 · Insomnia DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Daridorexant 50 mgPhase 3 · Insomnia DisorderClinicalTrials.gov · fetched Nov 12, 2026
- LucerastatPhase 3 · Fabry DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ACT-539313Phase 2 · Binge-Eating DisorderClinicalTrials.gov · fetched Nov 12, 2026
- ACT-777991Phase 2 · Non-Segmental VitiligoClinicalTrials.gov · fetched Nov 12, 2026
- Aprocitentan 10 mgPhase 2 · Essential HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Aprocitentan 25 mgPhase 2 · Essential HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Aprocitentan 5 mgPhase 2 · Essential HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Aprocitentan 50 mgPhase 2 · Essential HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Daridorexant 10 mgPhase 2 · InsomniaClinicalTrials.gov · fetched Nov 12, 2026
- Daridorexant 25 mgPhase 2 · InsomniaClinicalTrials.gov · fetched Nov 12, 2026
- Daridorexant 50 mgPhase 2 · InsomniaClinicalTrials.gov · fetched Nov 12, 2026
- Lisinopril 20 mgPhase 2 · Essential HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- AprocitentanPhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- Aprocitentan 25mgPhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- DaridorexantPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Daridorexant 10 mgPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Daridorexant 25 mgPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- MidalozamPhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- DaridorexantInsomniaClinicalTrials.gov · fetched Nov 12, 2026
- No insomnia medicationInsomniaClinicalTrials.gov · fetched Nov 12, 2026
- No insomnia medicationInsomnia DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Non-orexin receptor antagonist insomnia medicationInsomnia DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Non-orexin receptor antagonist medications for insomniaInsomniaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002PHASE2 · SUSPENDED · started May 1, 2028ClinicalTrials.gov NCT06816433 · fetched Nov 12, 2026
- A Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry DiseasePHASE3 · RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07778667 · fetched Nov 12, 2026
- A Trial to See if Daridorexant Can Help Adults and Elderly People With Insomnia Sleep Better During the Night and Function Better During the DayPHASE3 · RECRUITING · started Oct 28, 2026ClinicalTrials.gov NCT07843329 · fetched Nov 12, 2026
- A Study to Learn How Safe ACT-777991 is and How Well it Works in Adults With Non-segmental VitiligoPHASE2 · RECRUITING · started Oct 6, 2026ClinicalTrials.gov NCT07667569 · fetched Nov 12, 2026
- IMPACT-HTN Study of Patients With HypertensionNOT_YET_RECRUITING · started Jul 1, 2026ClinicalTrials.gov NCT07579260 · fetched Nov 12, 2026
- Sleep in Collegiate Baseball PlayersNA · COMPLETED · started Sep 16, 2025ClinicalTrials.gov NCT07212101 · fetched Nov 12, 2026
- Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®TERMINATED · started Nov 21, 2024ClinicalTrials.gov NCT06498128 · fetched Nov 12, 2026
- Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)ACTIVE_NOT_RECRUITING · started Nov 30, 2023ClinicalTrials.gov NCT06393504 · fetched Nov 12, 2026
- Department of Defense PTSD Adaptive Platform Trial - Master ProtocolPHASE2 · SUSPENDED · started Nov 2, 2023ClinicalTrials.gov NCT05422612 · fetched Nov 12, 2026
- Department of Defense PTSD Adaptive Platform Trial - Intervention C - DaridorexantPHASE2 · SUSPENDED · started Nov 2, 2023ClinicalTrials.gov NCT05948540 · fetched Nov 12, 2026
- Department of Defense PTSD Adaptive Platform Trial - Intervention A - FluoxetinePHASE2 · SUSPENDED · started Nov 2, 2023ClinicalTrials.gov NCT05948553 · fetched Nov 12, 2026
- A Phase 1 Trial to Investigate the Biological Equivalence of 5 × 10 mg Tablets and 2 × 25 mg Tablets of Daridorexant in Healthy Male and Female Japanese ParticipantsPHASE1 · COMPLETED · started Jun 23, 2023ClinicalTrials.gov NCT05877222 · fetched Nov 12, 2026
- A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid NocturiaPHASE4 · COMPLETED · started Feb 16, 2023ClinicalTrials.gov NCT05597020 · fetched Nov 12, 2026
- A Study to Measure Daridorexant in Breast Milk of Healthy Lactating WomenPHASE1 · COMPLETED · started Jan 16, 2023ClinicalTrials.gov NCT05632393 · fetched Nov 12, 2026
- Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia DisorderPHASE2 · COMPLETED · started Sep 6, 2022ClinicalTrials.gov NCT05423717 · fetched Nov 12, 2026
- Multicenter Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating DisorderPHASE2 · COMPLETED · started Feb 16, 2021ClinicalTrials.gov NCT04753164 · fetched Nov 12, 2026
- Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the BrainPHASE3 · COMPLETED · started Feb 3, 2019ClinicalTrials.gov NCT03585270 · fetched Nov 12, 2026
- A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry DiseasePHASE3 · COMPLETED · started Dec 18, 2018ClinicalTrials.gov NCT03737214 · fetched Nov 12, 2026
- A Study to Evaluate How Aprocitentan is Safe and How it is Absorbed and Broken Down in the Body of Japanese and Caucasian SubjectsPHASE1 · COMPLETED · started Jul 17, 2018ClinicalTrials.gov NCT03586570 · fetched Nov 12, 2026
- Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry DiseasePHASE3 · COMPLETED · started Jun 21, 2018ClinicalTrials.gov NCT03425539 · fetched Nov 12, 2026
- A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its SafetyPHASE3 · COMPLETED · started Jun 18, 2018ClinicalTrials.gov NCT03541174 · fetched Nov 12, 2026
- Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia DisorderPHASE3 · COMPLETED · started Jun 4, 2018ClinicalTrials.gov NCT03545191 · fetched Nov 12, 2026
- Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to SleepPHASE3 · COMPLETED · started May 29, 2018ClinicalTrials.gov NCT03575104 · fetched Nov 12, 2026
- A Study to Investigate the Effect of ACT-132577 on the Pharmacokinetics of Midazolam and 1-hydroxy Midazolam in Healthy Male SubjectsPHASE1 · COMPLETED · started Jul 1, 2016ClinicalTrials.gov NCT02841761 · fetched Nov 12, 2026
- Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential HypertensionPHASE2 · COMPLETED · started Dec 14, 2015ClinicalTrials.gov NCT02603809 · fetched Nov 12, 2026